Roche’s Tecentriq is the first I-O drug to claim a post-surgery win in lung cancer. But will doctors use it?

Roche’s Tecentriq is the first I-O drug to claim a post-surgery win in lung cancer. But will doctors use it?
aliu
Mon, 03/22/2021 – 08:28